News & Publications for:

Alan Pestronk

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

Posted on July 11, 2016

Bali T, Self W, Liu J, et al: 2016 Neurodegeneration, doi:10.1136/jnnp-2016-313521 Read More

Posted in: HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty: ,

Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis

Posted on June 5, 2016

Sansone VA, Burge J, McDermott MP, et al: 2016 Neurology, 86(15), pp 1408-1416 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

A randomized trial of mexiletine in ALS

Posted on June 5, 2016

Weiss MD, Macklin EA, Simmons Z, et al: 2016 Neurology, 86(16), pp 1474-1481 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

A genome-wide association study of myasthenia gravis

Posted on May 7, 2015

Renton AE, Pliner HA, Provenzano C, et al: 2015 JAMA Neurology, 72(4), pp 396-404 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Myovascular innervation: Axon loss in small-fiber neuropathies

Posted on April 9, 2015

Dori A, Lopate G, Keeling R, Pestronk A: 2015 Muscle and Nerve, 51(4), pp 514-521 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: